Tag: menveo market share

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Menveo Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

The growth witnessed during the historic period can be ascribed to the broadening of national immunization programs, past outbreaks of meningococcal disease, improvements in conjugate vaccine technology, heightened awareness regarding vaccine-preventable illnesses, and international vaccination campaigns.

The expansion during the projected timeframe can be linked to heightened investments in novel vaccine development, an intensified focus on preventing disease outbreaks, the broadened reach of immunization for adults and adolescents, the escalating need for travel-related vaccinations, and the reinforcement of public health infrastructure.

Significant trends expected in the forecast period involve the increasing uptake of conjugate vaccines, a greater emphasis on preventive immunization initiatives, a rising demand for vaccinations for adolescents and travelers, the expansion of multivalent vaccine coverage, and an enhanced focus on public health preparedness.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=31027844&type=smp&name=Menveo%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Menveo Market Development Factors: What’s Supporting Demand?

The rising incidence of meningitis is anticipated to fuel the expansion of the menveo market in the coming years. This condition involves the inflammation of the brain and spinal cord’s protective membranes, frequently caused by viral, bacterial, or fungal agents. The growing occurrence of meningitis is largely due to factors like increased global travel and compromised immune systems, both of which elevate the likelihood of disease spread. Menveo contributes to public health initiatives by offering defense against various strains of Neisseria meningitidis, facilitating prompt prevention, curbing the spread of the disease, and alleviating the impact of invasive meningococcal infections. For instance, in October 2025, according to the UK Health Security Agency, a UK-based government agency, a total of 378 invasive meningococcal disease (IMD) cases were confirmed in 2024–25. Consequently, the escalating prevalence of meningitis is a key driver for the menveo market’s expansion.

Menveo Market Segment Analysis Spotlighting Growth Areas

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

Menveo Market Transformation Trends: What Innovations Are Driving Change?

A significant development in the menveo market focuses on creating advanced vaccine formulations, particularly single-vial, fully liquid types, to boost convenience, improve stability, and streamline administration. These single-vial, fully liquid formulations are pharmaceutical products that come pre-mixed and packaged in a single vial, with their active ingredients already dissolved in liquid, ready for immediate use. An illustration of this is when GlaxoSmithKline (GSK) plc, a UK-based pharmaceutical industry company, secured approval from the European Commission (EC) in November 2024 for a new presentation of its meningococcal vaccine, Menveo. This approval is for active immunization against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. The vaccine is currently licensed for individuals aged two years and older, adolescents, and adults. Key aspects of this vaccine’s approval include its authorization for active immunization within the European Union for children from two years of age, adolescents, and adults, notably featuring a novel single-vial, fully liquid presentation that eliminates the requirement for reconstitution before use.

Menveo Market Leading Companies: Who Holds The Strongest Market Presence?

Major companies operating in the menveo market are GlaxoSmithKline (GSK) Plc

View The Full Menveo Market Report:

https://thebusinessresearchcompany.com/report/menveo-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Menveo Market Regional Split: Which Areas Are Fueling Growth?

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Menveo Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The expansion of national immunization programs, past outbreaks of meningococcal infections, progress in conjugate vaccine development, heightened public awareness regarding diseases that can be prevented through vaccination, and worldwide efforts to promote immunization all contributed to the growth observed during the historical period.

The increase anticipated during the forecast period is driven by higher funding for vaccine development, a stronger emphasis on preventing disease outbreaks, broader immunization initiatives targeting adults and adolescents, greater need for vaccines linked to travel, and enhanced public health systems. Key developments shaping this period involve a growing preference for conjugate vaccines, an intensified focus on preventive vaccination strategies, rising requirements for vaccines given to adolescents and travelers, expansion in the range of multivalent vaccines offered, and a reinforced commitment to public health readiness.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20153&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Menveo Market Growth Drivers And Industry Catalysts

The upward trend in meningitis cases is anticipated to boost demand for the menveo market in the coming period. Meningitis involves inflammation of the protective layers surrounding the brain and spinal cord, often caused by viral, bacterial, or fungal agents. The growing incidence of this condition is mainly fueled by heightened international travel and compromised immune systems, which facilitate easier transmission of the disease. Menveo contributes to public health initiatives by offering defense against various strains of Neisseria meningitidis, facilitating early intervention, curbing the spread of infection, and decreasing the impact of severe meningococcal illnesses. As reported by the UK Health Security Agency in October 2025, 378 cases of invasive meningococcal disease were documented during the 2024–25 period. Consequently, the rising prevalence of meningitis is fueling expansion in the menveo market.

The worldwide enhancement of healthcare infrastructure is set to accelerate growth in the menveo sector. Healthcare infrastructure encompasses the physical and organizational frameworks, facilities, resources, and systems required to deliver medical services to populations. This expansion is driven by factors such as an aging demographic, a surge in chronic conditions, and ongoing technological progress. Menveo, a meningococcal vaccine designed to prevent invasive meningococcal disease, takes advantage of this infrastructure through immunization efforts in clinics, hospitals, and community health campaigns. In May 2024, the UK-based Office for National Statistics reported that healthcare spending rose by 5.6% in nominal terms from 2022 to 2023, a notable increase compared to the 0.9% growth observed in 2022. As a result, the broadening of global healthcare infrastructure is propelling the menveo market forward.

Menveo Market Segmentation Trends And Revenue Drivers

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

Menveo Market Trends Influencing Long-Term Demand

A significant development in the Menveo market involves the creation of innovative vaccine formulations, particularly single-vial, fully liquid options that boost ease of use, enhance stability, and simplify how the vaccine is given. These single-vial, fully liquid formulations are pharmaceutical products where the active components are already dissolved in liquid and packaged together, ready for direct injection without any mixing. As an example, in November 2024, GlaxoSmithKline (GSK) plc, a pharmaceutical firm based in the United Kingdom, obtained approval from the European Commission (EC) for a new version of its meningococcal vaccine, Menveo, intended for active immunization against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. This vaccine is now authorized for use in children aged two and older, teenagers, and adults. The approval’s main highlights include its authorization for active immunization across the European Union for children starting from two years of age, adolescents, and adults, featuring a new single-vial, fully liquid format that removes the need for reconstitution prior to use.

Menveo Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the menveo market are GlaxoSmithKline (GSK) Plc

Access The Complete Menveo Market Report:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Menveo Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The Menveo Market Between 2026 And 2030?

Historically, the observed growth was propelled by the broadening of national immunization programs, previous outbreaks of meningococcal disease, progress in conjugate vaccine technology, heightened awareness of illnesses preventable by vaccines, and worldwide vaccination efforts.

The anticipated growth during the forecast period is propelled by heightened investments in vaccine development, a sharpened focus on preventing outbreaks, the broadening of immunization coverage for adults and adolescents, an uptick in demand for travel-related vaccinations, and the reinforcement of public health infrastructure.

Significant trends expected in the forecast period involve a greater uptake of conjugate vaccines, an increasing emphasis on proactive immunization programs, a rising need for adolescent and travel vaccinations, the expansion of multivalent vaccine coverage, and an enhanced commitment to public health readiness.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20153&type=smp

Which Growth Factors Are Strengthening The Menveo Market Landscape?

The increasing frequency of meningitis cases is anticipated to drive the expansion of the menveo market in the coming years. Meningitis, an infection, leads to inflammation of the protective membranes that envelop the brain and spinal cord, typically initiated by viral, bacterial, or fungal agents. The escalating incidence of meningitis is primarily influenced by factors such as heightened global movement and compromised immune systems, which elevate the chances of disease transmission. menveo plays a crucial role in public health by offering protection against various strains of Neisseria meningitidis, facilitating early prevention, curtailing disease spread, and diminishing the burden of invasive meningococcal infections. For example, in October 2025, as reported by the UK Health Security Agency, a UK-based government agency, a total of 378 invasive meningococcal disease (IMD) cases were confirmed in 2024–25. Consequently, the rising occurrence of meningitis is fueling the growth of the menveo market.

Menveo Market Driver: Impact Of Global Healthcare Infrastructure Expansion On Market Growth

How Are Different Segment Groups Identified Within The Menveo Market?

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

Which Trends Are Influencing The Expansion Of The Menveo Market?

A significant trend in the menveo market focuses on developing innovative vaccine formulations, such as single-vial, fully liquid preparations, to enhance user convenience, improve stability, and simplify the administration process. These single-vial, fully liquid formulations are pharmaceutical products that come pre-mixed and packaged in a single vial, with their active ingredients already dissolved in a liquid state, ready for immediate use. For instance, in November 2024, GlaxoSmithKline (GSK) plc, a UK-based pharmaceutical company, secured approval from the European Commission (EC) for a new presentation of its meningococcal vaccine, Menveo, designed for active immunization against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. The vaccine is now licensed for application in children aged two years and older, adolescents, and adults. The core aspects of this vaccine’s approval include its licensing for active immunization within the European Union for children from two years of age, adolescents, and adults, featuring a novel single-vial, fully liquid presentation that eliminates the requirement for reconstitution before use.

Who Are The Businesses Driving Activity In The Menveo Market?

Major companies operating in the menveo market are GlaxoSmithKline (GSK) Plc

Access The Complete Menveo Market Report:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report

Which Region Accounts For The Highest Share Of The Menveo Market?

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Menveo Market In 2026 And 2030?

The historical period’s growth can be linked to the broadening of national immunization programs, past occurrences of meningococcal disease outbreaks, improvements in conjugate vaccine technology, a greater understanding of diseases preventable by vaccines, and worldwide vaccination efforts.

Growth in the forecast period can be attributed to escalating investments in vaccine innovation, a heightened focus on preventing outbreaks, the broadening of immunization coverage for adults and adolescents, surging demand for travel-related vaccinations, and the fortification of public health infrastructure. Significant trends anticipated during this period include the increased adoption of conjugate vaccines, a rising emphasis on preventive immunization programs, growing demand for adolescent and travel-related immunizations, the expansion of multivalent vaccine availability, and an enhanced commitment to public health preparedness.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20153&type=smp

What Key Drivers Are Fueling The Growth Of The Menveo Market?

The increasing frequency of meningitis cases is anticipated to drive the expansion of the menveo market in the coming years. Meningitis, an infection, leads to inflammation of the protective membranes that envelop the brain and spinal cord, typically initiated by viral, bacterial, or fungal agents. The escalating incidence of meningitis is primarily influenced by factors such as heightened global movement and compromised immune systems, which elevate the chances of disease transmission. menveo plays a crucial role in public health by offering protection against various strains of Neisseria meningitidis, facilitating early prevention, curtailing disease spread, and diminishing the burden of invasive meningococcal infections. For example, in October 2025, as reported by the UK Health Security Agency, a UK-based government agency, a total of 378 invasive meningococcal disease (IMD) cases were confirmed in 2024–25. Consequently, the rising occurrence of meningitis is fueling the growth of the menveo market.

Menveo Market Driver: Impact Of Global Healthcare Infrastructure Expansion On Market Growth

What Are The Different Segment Types In The Menveo Market Segment Breakdown?

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

What Trends Are Shaping The Future Of The Menveo Market?

A significant trend in the menveo market involves the creation of innovative vaccine formulations, such as single-vial, fully liquid preparations, intended to boost convenience, enhance stability, and streamline vaccine administration. Single-vial, fully liquid formulations refer to pharmaceutical products that are pre-mixed and contained in a single vial, with the active ingredients dissolved in a liquid form, ready for immediate use. For instance, in November 2024, GlaxoSmithKline (GSK) plc, a UK-based pharmaceutical industry company, secured approval from the European Commission (EC) for a new presentation of its meningococcal vaccine, Menveo, for active immunization against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. The vaccine is now licensed for use in children aged two years and older, adolescents, and adults. Key features of the vaccine’s approval include its authorization for active immunization in the European Union for children from two years of age, adolescents, and adults, with a new single-vial, fully liquid presentation that removes the requirement for reconstitution before use.

Who Are The Well-Known Companies In The Menveo Market?

Major companies operating in the menveo market are GlaxoSmithKline (GSK) Plc

Get The Full Menveo Market Report:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report

Which Region Leads The Menveo Market In Overall Market Size?

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Menveo Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report

Browse Through More Reports Similar to the Global Menveo Market 2026, By The Business Research Company

Renewable Diesel Market Report 2026

https://www.thebusinessresearchcompany.com/report/renewable-diesel-global-market-report

Hypermarkets Market Report 2026

https://www.thebusinessresearchcompany.com/report/hypermarkets-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Menveo Market Projected To Become By 2030 Based On Its 2026 Valuation?

Historical growth stemmed from the broadening of national immunization programs, past occurrences of meningococcal disease outbreaks, improvements in conjugate vaccine technology, enhanced public understanding of diseases preventable by vaccination, and global immunization efforts.

Anticipated expansion during the forecast period is fueled by escalating investments in vaccine innovation, a heightened focus on preventing outbreaks, the broadening of adult and adolescent immunization coverage, an uptick in demand for travel-related vaccinations, and the reinforcement of public health infrastructure. Additionally, significant trends anticipated during this period involve the increasing uptake of conjugate vaccines, an intensified focus on preventive immunization strategies, expanding demand for adolescent and travel vaccinations, the wider deployment of multivalent vaccine coverage, and a greater emphasis on public health readiness.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20153&type=smp

What Drivers Are Shaping The Future Growth Of The Menveo Market?

The increasing incidence of meningitis is projected to fuel the expansion of the menveo market in the coming years. Meningitis is an infection characterized by inflammation of the protective membranes surrounding the brain and spinal cord, commonly triggered by viral, bacterial, or fungal agents. The escalating prevalence of meningitis is primarily driven by factors such as enhanced global travel and weakened immune systems, both of which amplify the risk of disease transmission. Menveo contributes to public health initiatives by offering protection against various strains of Neisseria meningitidis, thereby enabling early prevention, curtailing disease dissemination, and lessening the impact of invasive meningococcal infections. For instance, in October 2025, the UK Health Security Agency, a UK-based government body, reported a total of 378 confirmed invasive meningococcal disease (IMD) cases during the 2024–25 period. Consequently, the rising prevalence of meningitis is a key factor driving the growth of the menveo market. Menveo Market Driver: Impact Of Global Healthcare Infrastructure Expansion On Market Growth

What Segment Groups Are Identified Within The Menveo Market?

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

What Trends Are Advancing Progress In The Menveo Market?

A significant development in the Menveo market is the creation of innovative vaccine formulations, such as single-vial, fully liquid preparations, designed to improve convenience, enhance stability, and simplify vaccine administration. These single-vial, fully liquid formulations refer to pharmaceutical products that are pre-mixed and packaged in a single vial, with the active ingredients already dissolved in liquid form, ready for use. For instance, in November 2024, GlaxoSmithKline (GSK) plc, a UK-based pharmaceutical industry company, secured approval from the European Commission (EC) for a new version of its meningococcal vaccine, Menveo, intended for active immunization against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. The vaccine is now authorized for use in children aged two years and older, adolescents, and adults. Key aspects of this approval for the vaccine include its licensing for active immunization within the European Union for children from two years of age, adolescents, and adults, featuring a new single-vial, fully liquid presentation that eliminates the need for reconstitution prior to administration.

Which Companies Hold Significant Positions In The Menveo Market?

Major companies operating in the menveo market are GlaxoSmithKline (GSK) Plc

Read the full menveo market report here:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report

Which Geographic Regions Are Influencing Demand In The Menveo Market?

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Menveo Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20153&type=smp

Browse Through More Reports Similar to the Global Menveo Market 2026, By The Business Research Company

Renewable Diesel Market Report 2026

https://www.thebusinessresearchcompany.com/report/renewable-diesel-global-market-report

Hypermarkets Market Report 2026

https://www.thebusinessresearchcompany.com/report/hypermarkets-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Menveo Market Projected To Become By 2030 Based On Its 2026 Valuation?

Historical growth stemmed from the broadening of national immunization programs, past occurrences of meningococcal disease outbreaks, improvements in conjugate vaccine technology, enhanced public understanding of diseases preventable by vaccination, and global immunization efforts.

Anticipated expansion during the forecast period is fueled by escalating investments in vaccine innovation, a heightened focus on preventing outbreaks, the broadening of adult and adolescent immunization coverage, an uptick in demand for travel-related vaccinations, and the reinforcement of public health infrastructure. Additionally, significant trends anticipated during this period involve the increasing uptake of conjugate vaccines, an intensified focus on preventive immunization strategies, expanding demand for adolescent and travel vaccinations, the wider deployment of multivalent vaccine coverage, and a greater emphasis on public health readiness.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20153&type=smp

What Drivers Are Shaping The Future Growth Of The Menveo Market?

The increasing incidence of meningitis is projected to fuel the expansion of the menveo market in the coming years. Meningitis is an infection characterized by inflammation of the protective membranes surrounding the brain and spinal cord, commonly triggered by viral, bacterial, or fungal agents. The escalating prevalence of meningitis is primarily driven by factors such as enhanced global travel and weakened immune systems, both of which amplify the risk of disease transmission. Menveo contributes to public health initiatives by offering protection against various strains of Neisseria meningitidis, thereby enabling early prevention, curtailing disease dissemination, and lessening the impact of invasive meningococcal infections. For instance, in October 2025, the UK Health Security Agency, a UK-based government body, reported a total of 378 confirmed invasive meningococcal disease (IMD) cases during the 2024–25 period. Consequently, the rising prevalence of meningitis is a key factor driving the growth of the menveo market. Menveo Market Driver: Impact Of Global Healthcare Infrastructure Expansion On Market Growth

What Segment Groups Are Identified Within The Menveo Market?

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

What Trends Are Advancing Progress In The Menveo Market?

A significant development in the Menveo market is the creation of innovative vaccine formulations, such as single-vial, fully liquid preparations, designed to improve convenience, enhance stability, and simplify vaccine administration. These single-vial, fully liquid formulations refer to pharmaceutical products that are pre-mixed and packaged in a single vial, with the active ingredients already dissolved in liquid form, ready for use. For instance, in November 2024, GlaxoSmithKline (GSK) plc, a UK-based pharmaceutical industry company, secured approval from the European Commission (EC) for a new version of its meningococcal vaccine, Menveo, intended for active immunization against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. The vaccine is now authorized for use in children aged two years and older, adolescents, and adults. Key aspects of this approval for the vaccine include its licensing for active immunization within the European Union for children from two years of age, adolescents, and adults, featuring a new single-vial, fully liquid presentation that eliminates the need for reconstitution prior to administration.

Which Companies Hold Significant Positions In The Menveo Market?

Major companies operating in the menveo market are GlaxoSmithKline (GSK) Plc

Read the full menveo market report here:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report

Which Geographic Regions Are Influencing Demand In The Menveo Market?

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Menveo Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20153&type=smp

Browse Through More Reports Similar to the Global Menveo Market 2026, By The Business Research Company

Renewable Diesel Market Report 2026

https://www.thebusinessresearchcompany.com/report/renewable-diesel-global-market-report

Hypermarkets Market Report 2026

https://www.thebusinessresearchcompany.com/report/hypermarkets-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Menveo Market Projected To Become By 2030 Based On Its 2026 Valuation?

Historical growth stemmed from the broadening of national immunization programs, past occurrences of meningococcal disease outbreaks, improvements in conjugate vaccine technology, enhanced public understanding of diseases preventable by vaccination, and global immunization efforts.

Anticipated expansion during the forecast period is fueled by escalating investments in vaccine innovation, a heightened focus on preventing outbreaks, the broadening of adult and adolescent immunization coverage, an uptick in demand for travel-related vaccinations, and the reinforcement of public health infrastructure. Additionally, significant trends anticipated during this period involve the increasing uptake of conjugate vaccines, an intensified focus on preventive immunization strategies, expanding demand for adolescent and travel vaccinations, the wider deployment of multivalent vaccine coverage, and a greater emphasis on public health readiness.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20153&type=smp

What Drivers Are Shaping The Future Growth Of The Menveo Market?

The increasing incidence of meningitis is projected to fuel the expansion of the menveo market in the coming years. Meningitis is an infection characterized by inflammation of the protective membranes surrounding the brain and spinal cord, commonly triggered by viral, bacterial, or fungal agents. The escalating prevalence of meningitis is primarily driven by factors such as enhanced global travel and weakened immune systems, both of which amplify the risk of disease transmission. Menveo contributes to public health initiatives by offering protection against various strains of Neisseria meningitidis, thereby enabling early prevention, curtailing disease dissemination, and lessening the impact of invasive meningococcal infections. For instance, in October 2025, the UK Health Security Agency, a UK-based government body, reported a total of 378 confirmed invasive meningococcal disease (IMD) cases during the 2024–25 period. Consequently, the rising prevalence of meningitis is a key factor driving the growth of the menveo market. Menveo Market Driver: Impact Of Global Healthcare Infrastructure Expansion On Market Growth

What Segment Groups Are Identified Within The Menveo Market?

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

What Trends Are Advancing Progress In The Menveo Market?

A significant development in the Menveo market is the creation of innovative vaccine formulations, such as single-vial, fully liquid preparations, designed to improve convenience, enhance stability, and simplify vaccine administration. These single-vial, fully liquid formulations refer to pharmaceutical products that are pre-mixed and packaged in a single vial, with the active ingredients already dissolved in liquid form, ready for use. For instance, in November 2024, GlaxoSmithKline (GSK) plc, a UK-based pharmaceutical industry company, secured approval from the European Commission (EC) for a new version of its meningococcal vaccine, Menveo, intended for active immunization against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. The vaccine is now authorized for use in children aged two years and older, adolescents, and adults. Key aspects of this approval for the vaccine include its licensing for active immunization within the European Union for children from two years of age, adolescents, and adults, featuring a new single-vial, fully liquid presentation that eliminates the need for reconstitution prior to administration.

Which Companies Hold Significant Positions In The Menveo Market?

Major companies operating in the menveo market are GlaxoSmithKline (GSK) Plc

Read the full menveo market report here:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report

Which Geographic Regions Are Influencing Demand In The Menveo Market?

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Menveo Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20153&type=smp

Browse Through More Reports Similar to the Global Menveo Market 2026, By The Business Research Company

Renewable Diesel Market Report 2026

https://www.thebusinessresearchcompany.com/report/renewable-diesel-global-market-report

Hypermarkets Market Report 2026

https://www.thebusinessresearchcompany.com/report/hypermarkets-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the menveo market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Menveo Market in 2030?

Several key elements have contributed to the growth observed in the historic period. These include the expansion of national immunization programs, past outbreaks of meningococcal disease, significant advancements in conjugate vaccine technology, a heightened awareness of illnesses preventable by vaccines, and global vaccination efforts.

The anticipated growth during the forecast period is attributed to increasing investments in vaccine innovation, a rising focus on preventing outbreaks, the expansion of immunization coverage for adults and adolescents, growing demand for travel-related vaccinations, and the strengthening of public health infrastructure. Concurrently, major trends expected in this timeframe include the wider adoption of conjugate vaccines, a heightened emphasis on preventive immunization programs, increasing demand for adolescent and travel vaccinations, broader coverage of multivalent vaccines, and an enhanced focus on public health preparedness.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20153&type=smp

What Drivers Are Influencing Production Trends In The Menveo Market?

The menveo market is anticipated to expand due to the rising occurrence of meningitis. This condition involves the inflammation of the brain and spinal cord’s protective membranes, typically caused by viruses, bacteria, or fungi. The increased incidence of meningitis stems mainly from factors such as enhanced worldwide movement and compromised immune systems, which elevate the chances of disease transmission. Menveo plays a crucial role in public health initiatives by offering defense against various strains of Neisseria meningitidis, thereby facilitating prompt prevention, decreasing disease dissemination, and diminishing the impact of invasive meningococcal infections. For example, in October 2025, the UK Health Security Agency, a government body based in the UK, reported 378 confirmed cases of invasive meningococcal disease (IMD) during 2024–25. Consequently, the growing prevalence of meningitis is fueling the expansion of the menveo market.

Which Segment Groups Are Influencing The Menveo Market?

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

What Industry Trends Are Transforming The Menveo Market?

A primary trend within the menveo market involves the creation of advanced vaccine formulations, including single-vial, fully liquid options, aimed at boosting convenience, enhancing stability, and streamlining vaccine delivery. These single-vial, fully liquid formulations are defined as pharmaceutical preparations that come pre-mixed and contained within a single vial, where the active components are already dissolved in liquid, prepared for immediate use. As an example, in November 2024, GlaxoSmithKline (GSK) plc, a pharmaceutical firm based in the UK, secured approval from the European Commission (EC) for an updated version of its meningococcal vaccine, Menveo, for active immunization against invasive meningococcal disease (IMD) resulting from serogroups A, C, W, and Y. This vaccine is now authorized for administration to children aged two years and above, adolescents, and adults. Significant aspects of this vaccine’s approval encompass its authorization for active immunization across the European Union for individuals starting from two years old, including adolescents and adults, notably featuring a novel single-vial, fully liquid format that removes the necessity for reconstitution prior to use.

Who Are The Primary Competitors In The Global Menveo Market?

Major companies operating in the menveo market are GlaxoSmithKline (GSK) Plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Menveo Market?

North America was the largest region in the menveo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Menveo Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20153&type=smp

Browse Through More Reports Similar to the Global Menveo Market 2026, By The Business Research Company

Renewable Diesel Market Report 2026

https://www.thebusinessresearchcompany.com/report/renewable-diesel-global-market-report

Hypermarkets Market Report 2026

https://www.thebusinessresearchcompany.com/report/hypermarkets-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Menveo Market Expected to Grow Between 2025 And 2029?

The market size of Menveo has recently seen an increase of XX (HCAGR). Further projections indicate that it will expand from a valuation of $XX million in 2024 to $XX million in 2025, marking a compound annual growth rate (CAGR) of XX%. This positive trend from the past can be traced back to strategies such as public immunization initiatives, the high incidence of meningococcal disease, robust healthcare systems, regulations for international travel, and compulsory vaccinations in the military.

What Growth Rate Is Anticipated for the Menveo Market in the Coming Years?

The market size of Menveo is anticipated to observe XX (FCAGR) growth in the forthcoming years, inflating to a value of $XX million by 2029 at a CAGR of XX%. This projected growth during the forecast tenure is expected to be driven by factors such as a surge in population, increased awareness about healthcare, escalating travel trends, augmenting vaccination requirements in academic institutions, and advancements in emerging markets. The major market trends to dominate the forecast period encompass a surge in combination vaccines, emphasizing booster doses, growing demand from budding economies, improvement in cold-chain distribution, and strategic partnerships for better market infiltration.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20153&type=smp

Who Are the Leading Companies in the Menveo Market?

Major companies operating in the menveo market include GlaxoSmithKline (GSK) Plc

What Are the Key Drivers of the Menveo Market?

The rise in meningitis cases is predicted to drive the growth of the menveo market in the future. Meningitis, an infection that causes inflammation of the protective layers (meninges) surrounding the brain and spinal cord, can be triggered by a range of factors, such as viral, bacterial, or fungal infections. The disease spread is also exacerbated by antibiotic resistance, weakened immunity, and increased global travel. Menveo, a vaccine against meningococcal disease, aids in curbing the meningitis prevalence by shielding against multiple strains of Neisseria meningitides, a primary source of bacterial meningitis. Its extensive use in immunization schedules aids in preventing disease outbreaks and lessening its transfer. For example, the meningococcal reference unit (MRU) of the UK Health Security Agency, a UK government agency, confirmed 396 instances of invasive meningococcal disease (IMD) from 2022 to 2023 in August 2024, showing a significant rise from the 205 cases reported from 2021 to 2022. Consequently, the escalating prevalence of meningitis is fueling the expansion of the menveo market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20153&type=smp

What Are the Key Market Segments in the Menveo Industry?

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

What Are the Latest Trends in the Menveo Market?

One significant trend in the Menveo market is the creation of novel vaccine formulations, such as single-vial, completely liquid versions, for greater ease of use, increased stability, and simplified administration. These single-vial, fully liquid formulations are essentially pre-mixed pharmaceutical products packaged in a single container, with active ingredients already dissolved and prepared for injection. As an example, in November 2024, GlaxoSmithKline (GSK) plc, a pharmaceutical company based in the UK, gained approval from the European Commission (EC) for a fresh version of its meningococcal vaccine, Menveo, intended for active immunization against the invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. The vaccine is now licensed for application in children over two years old, adolescents, and adults. Among the notable aspects of the vaccine’s approval include its licensing for active immunization in the European Union targeting children aged two and above, adolescents, and adults, with the new single-vial, fully liquid presentation eliminating the requirement for reconstitution prior to use.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report

What Are the Key Regional Markets in the Menveo Industry?

North America was the largest region in the menveo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20153

This Report Delivers Insight On:

1. How big is the menveo market, and how is it changing globally?

2. Who are the major companies in the menveo market, and how are they performing?

3. What are the key opportunities and risks in the menveo market right now?

4. Which products or customer segments are growing the most in the menveo market?

5. What factors are helping or slowing down the growth of the menveo market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the menveo global market report 2025 industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Menveo Market Through 2034?

In recent years, the Menveo market has experienced a size increase of XX (HCAGR). Starting from $XX million in 2024, it is predicted to expand at a compound annual growth rate (CAGR) of XX%, reaching a size of $XX million in 2025. The historical growth of this market is attributed to factors such as public immunization initiatives, the significant burden of meningococcal disease, robust healthcare infrastructure, mandatory military vaccinations, and prerequisites for international travel.

In the coming years, the Menveo market size is predicted to witness an XX (FCAGR) expansion. By 2029, it’s expected to mature to a whopping $XX million, with a compound annual growth rate (CAGR) of XX%. This upswing during the forecast period can be tied to factors such as population growth, heightened awareness of healthcare, an increase in travel and school vaccination requirements, and the widening of emerging markets. The forecast period will also see significant trends like the growth of combination vaccines, emphasis on booster doses, rising demand in nascent economies, improvements in cold chain distribution, and strategic partnerships for market penetration.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20153&type=smp

What Are the Core Market Drivers Propelling Growth in the Menveo Industry?

The escalating occurrence of meningitis is projected to drive the expansion of the menveo market in the future. Meningitis, an ailment that triggers inflammation in the protective membranes (meninges) enveloping the brain and spinal cord, can be instigated by a variety of sources such as viral, bacterial, or fungal intrusions. Furthermore, elements like antibiotic resistance, debilitated immune systems, and worldwide mobility play a role in spreading the disease. Menveo, a vaccine for meningococcal, plays a vital role in curbing the prevalence of meningitis by offering protection against multiple strains of Neisseria meningitides, a common source of bacterial meningitis. The broad-based usage of Menveo in immunisation schemes aids in averting outbreaks and mitigating the transmission of the disease. For example, the UK Health Security Agency, a governmental agency based in the UK, revealed that the meningococcal reference unit (MRU) acknowledged 396 instances of invasive meningococcal disease (IMD) from 2022 to 2023 in August 2024, marking a noticeable escalation from the 205 instances documented in 2021 to 2022. Thus, the growing occurrence of meningitis is facilitating the enlargement of the menveo market.

How Is the Menveo Market Segmented?

The menveo market covered in this report is segmented –

1) By Type of Vaccine: Conjugate Vaccine, Combination Vaccine

2) By Indication: Meningococcal Disease Prevention, Routine Immunization, Outbreak Control, Travel Vaccination

3) By Age Group: Infants and Young Children, Adolescents, Adults, Older Adults

4) By End User: Hospitals, Vaccination Clinics, Travel Clinics, Academic And Research Institutions, Military And Government Facilities

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20153&type=smp

Which Regions Are Driving the Next Phase of the Menveo Market Growth?

North America was the largest region in the menveo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menveo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Menveo Industry?

In the Menveo market, a central trend is the invention of new vaccine compositions like single-vial, fully liquid arrangements, which heighten convenience, bolster stability, and streamline vaccine application. These preparations consist of pre-mixed pharmaceutical products contained in a single vial, in which the active components are dissolved, primed for use. For example, in November 2024, UK-based pharmaceutical company GlaxoSmithKline (GSK) plc received European Commission (EC) approval for a new version of its Menveo vaccine, aimed at actively fortifying against invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y. This vaccine is currently permitted in the European Union for use in children aged two and above, adolescents, and adults. This approval includes significant features like its licensing for active vaccination in the European Union for children starting from the age of two, adolescents, and adults, with a novel single-vial, fully liquid format that removes the requirement for reconstitution prior to use.

View the full report here:

https://www.thebusinessresearchcompany.com/report/menveo-global-market-report

How Is the Menveo Market Defined and What Are Its Core Parameters?

Menveo is a meningococcal vaccine that protects against infections caused by Neisseria meningitidis. It targets serogroups A, C, W, and Y, which can cause meningitis and bloodstream infections. The vaccine is recommended for adolescents, young adults, and individuals at higher risk of meningococcal disease.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20153

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model